ARWR
Arrowhead Pharmaceuticals, Inc.Company with tickers: ARWR
CIK
879407
CUSIP
04280A100
Shares Outstanding
140,857,021
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $337,770,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $438,221,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $350,456,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-100,451,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-101,919,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.73 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.73 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |